Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ze Zhao

Showing results (201-210 of 212) with videos related to

Pageof 22
Sort By:
British Journal of Haematology|April 17, 2023
Efficacy of ruxolitinib for HAVCR2 mutation-associated hemophagocytic lymphohistiocytosis and panniculitis manifestations in childrenQing Zhang, Chun-Ju Zhou, Dan-Hong Li, et al.
Cancer Research and Treatment|September 25, 2020
Effectiveness and Safety of Dabrafenib in the Treatment of 20 Chinese Children with BRAFV600E-Mutated Langerhans Cell HistiocytosisYing Yang, Dong Wang, Lei Cui, et al.
Experimental and Therapeutic Medicine|February 28, 2020
Extracellular production of recombinant <i>sus scrofa</i> trefoil factor 3 by <i>Brevibacillus choshinensis</i>He-Ping Li, Chun-Mei Xu, Bing-Yan Wen, et al.
World Journal of Pediatrics : WJP|March 22, 2020
Associations between PRF1 Ala91Val polymorphism and risk of hemophagocytic lymphohistiocytosis: a meta-analysis based on 1366 subjectsGuang-Hua Zhu, Li-Ping Zhang, Zhi-Gang Li, et al.
BMC Genomics|February 17, 2024
Decoding the complexity of on-target integration: characterizing DNA insertions at the CRISPR-Cas9 targeted locus using nanopore sequencingJuan-Juan Zhao, Xin-Yu Sun, Sai-Ning Tian, et al.
Jornal De Pediatria|September 12, 2024
The clinical impact of serum soluble CD25 levels in children with Langerhans cell histiocytosisZi-Jing Zhao, Hong-Yun Lian, Wei-Jing Li, et al.
Jornal De Pediatria|November 1, 2025
Peripheral immune indicators and their predictive value in disease progression or relapse of pediatric Langerhans cell histiocytosisHua-Lin Li, Hong-Yun Lian, Wen-Yu Gong, et al.
Haematologica|November 27, 2025
Cell-free BRAF-V600E levels predict progression-free survival in children with Langerhans cell histiocytosis treated with dabrafenib and maintenance chemotherapyLei Cui, Dong Wang, Yun-Ze Zhao, et al.
Archives of Pathology & Laboratory Medicine|May 15, 2024
Genetic Landscape and Its Prognostic Impact in Children With Langerhans Cell HistiocytosisChan-Juan Wang, Lei Cui, Shuang-Shuang Li, et al.
Annals of Surgical Oncology|September 10, 2025
Development and Validation of an Individualized Prediction Model for Postoperative Late Recurrence After Hepatectomy for Hepatocellular Carcinoma (POLAR-HCC): A Multicenter StudyXin-Fei Xu, Han Wu, Li-Hui Gu, et al.
Pageof 22

Showing results (201-210 of 212) with videos related to

Sort By:
Pageof 22
British Journal of Haematology|April 17, 2023
Efficacy of ruxolitinib for HAVCR2 mutation-associated hemophagocytic lymphohistiocytosis and panniculitis manifestations in childrenQing Zhang, Chun-Ju Zhou, Dan-Hong Li, et al.
Cancer Research and Treatment|September 25, 2020
Effectiveness and Safety of Dabrafenib in the Treatment of 20 Chinese Children with BRAFV600E-Mutated Langerhans Cell HistiocytosisYing Yang, Dong Wang, Lei Cui, et al.
Experimental and Therapeutic Medicine|February 28, 2020
Extracellular production of recombinant <i>sus scrofa</i> trefoil factor 3 by <i>Brevibacillus choshinensis</i>He-Ping Li, Chun-Mei Xu, Bing-Yan Wen, et al.
World Journal of Pediatrics : WJP|March 22, 2020
Associations between PRF1 Ala91Val polymorphism and risk of hemophagocytic lymphohistiocytosis: a meta-analysis based on 1366 subjectsGuang-Hua Zhu, Li-Ping Zhang, Zhi-Gang Li, et al.
BMC Genomics|February 17, 2024
Decoding the complexity of on-target integration: characterizing DNA insertions at the CRISPR-Cas9 targeted locus using nanopore sequencingJuan-Juan Zhao, Xin-Yu Sun, Sai-Ning Tian, et al.
Jornal De Pediatria|September 12, 2024
The clinical impact of serum soluble CD25 levels in children with Langerhans cell histiocytosisZi-Jing Zhao, Hong-Yun Lian, Wei-Jing Li, et al.
Jornal De Pediatria|November 1, 2025
Peripheral immune indicators and their predictive value in disease progression or relapse of pediatric Langerhans cell histiocytosisHua-Lin Li, Hong-Yun Lian, Wen-Yu Gong, et al.
Haematologica|November 27, 2025
Cell-free BRAF-V600E levels predict progression-free survival in children with Langerhans cell histiocytosis treated with dabrafenib and maintenance chemotherapyLei Cui, Dong Wang, Yun-Ze Zhao, et al.
Archives of Pathology & Laboratory Medicine|May 15, 2024
Genetic Landscape and Its Prognostic Impact in Children With Langerhans Cell HistiocytosisChan-Juan Wang, Lei Cui, Shuang-Shuang Li, et al.
Annals of Surgical Oncology|September 10, 2025
Development and Validation of an Individualized Prediction Model for Postoperative Late Recurrence After Hepatectomy for Hepatocellular Carcinoma (POLAR-HCC): A Multicenter StudyXin-Fei Xu, Han Wu, Li-Hui Gu, et al.
Pageof 22